Commentary and Opinion by R. Lewis Dark

Why Labs Operate in a ‘Duality’ during Pandemic

HAS IT OCCURRED TO MANY OF YOU THAT YOUR CLINICAL LABORATORIES today must operate in what I will describe as an operational “duality”?  On one side, your lab must deal with COVID-19 testing. This is true whether your lab performs molecular SARS-CoV-2 tests or simply handles specimens that you refer to other labs for testing. …

Why Labs Operate in a ‘Duality’ during Pandemic Read More »

COVID-19 or Not, Lab Market Enters ‘Twilight Zone’

Our healthcare system is in a most remarkable state. Even as all providers—including clinical laboratories and anatomic pathology groups—continue to devote considerable resources to meeting the urgent need for SARS-CoV-2 testing, health insurers and regulators continue to issue new requirements governing all aspects of “normal” lab testing activities.  Today, all clinical labs and pathology groups …

COVID-19 or Not, Lab Market Enters ‘Twilight Zone’ Read More »

Lab Leaders Say COVID-19 Tests Needed in 2021

How long into the future will clinical laboratories need to offer COVID-19 tests on a large scale? That is the number one question confronting labs in every region of the United States. Last week, three nationally-known lab CEOs answered that question during the general session of the Virtual Executive War College. It was a panel discussion moderated by Robert …

Lab Leaders Say COVID-19 Tests Needed in 2021 Read More »

Lab Finances to Become More Challenging

When you finish reading our story about how Medicare spending for molecular and genetic tests jumped by as much as 700% in certain states during 2019, you’ll be among the first in the nation to understand why a financial crisis is soon to wash over those clinical laboratories and pathology groups that perform genetic tests. We thank Bruce Quinn, …

Lab Finances to Become More Challenging Read More »

Labs Adjust to COVID-19 as a Regular Part of Care

ONE INTERESTING NEW DEVELOPMENT NOT REPORTED MUCH BY THE NATIONAL MEDIA is that the daily number of new COVID-19 cases in the United States has declined steadily in the past month. It is too early to understand the implications of this development, but clinical lab administrators and pathologists may want to follow a basic statistic. Here at The Dark …

Labs Adjust to COVID-19 as a Regular Part of Care Read More »

COVID-19 Changes Lab and Pathology Profession

WE ARE ENTERING THE SEVENTH MONTH OF THE SARS-COV-2 OUTBREAK and some public health authorities predict that new cases of COVID-19 will continue through the fall and into 2021. If true, this will not be auspicious for the nation’s clinical laboratories and anatomic pathology groups. The current clinical and business model of clinical laboratory and anatomic pathology operations …

COVID-19 Changes Lab and Pathology Profession Read More »

It’s a Clinical Lab Moment … But No Advocates!

Nearly every day since the onset of the SARS-C0V-2 outbreak, there have been stories in the national news about clinical laboratory testing for COVID-19. No laboratory professional alive today has seen such an endless stream of news stories about clinical lab testing. This is a once-in-a-lifetime event that could be quite favorable to the clinical lab profession. Unfortunately, …

It’s a Clinical Lab Moment … But No Advocates! Read More »

Where Is the FDA When Labs Need It Most?

LET’S START WITH AN ESSENTIAL FACT: in the management of almost every outbreak of a novel infectious disease, clinical laboratory tests will be essential in diagnosis of the disease, in monitoring the progress of an infected patient, and in determining if, once cured, a patient has immunity to that disease. Next, let’s recognize another basic fact: clinical lab …

Where Is the FDA When Labs Need It Most? Read More »